{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:35:20Z","timestamp":1782603320495,"version":"3.54.5"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T00:00:00Z","timestamp":1528329600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11255-018-1906-x","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T11:53:44Z","timestamp":1528372424000},"page":"1871-1877","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prevalence and risk factors for hypercalcemia among non-dialysis patients with chronic kidney disease-mineral and bone disorder"],"prefix":"10.1007","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3039-3816","authenticated-orcid":false,"given":"Jun Jie Benjamin","family":"Seng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying Lin Cheryl","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rou Wei","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui Ting Sarah","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puay Hoon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiunn","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,6,7]]},"reference":[{"issue":"9888","key":"1906_CR1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/s0140-6736(13)60687-x","volume":"382","author":"V Jha","year":"2013","unstructured":"Jha V, Garcia-Garcia G, Iseki K, Li Z, Naicker S, Plattner B, Saran R, Wang AY, Yang CW (2013) Chronic kidney disease: global dimension and perspectives. Lancet 382(9888):260\u2013272. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(13)60687-x","journal-title":"Lancet"},{"key":"1906_CR2","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12955-016-0477-8","volume":"14","author":"H-L Wee","year":"2016","unstructured":"Wee H-L, Seng BJJ, Lee JJ, Chong KJ, Tyagi P, Vathsala A, How P (2016) Association of anemia and mineral and bone disorder with health-related quality of life in Asian pre-dialysis patients. Health Qual Life Outcomes 14:94. \n                    https:\/\/doi.org\/10.1186\/s12955-016-0477-8","journal-title":"Health Qual Life Outcomes"},{"issue":"6","key":"1906_CR3","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1681\/asn.2004040275","volume":"16","author":"Y Slinin","year":"2005","unstructured":"Slinin Y, Foley RN, Collins AJ (2005) Calcium, phosphorus, parathyroid hormone, and cardiovascular disease in hemodialysis patients: the USRDS waves 1, 3, and 4 study. J Am Soc Nephrol 16(6):1788\u20131793. \n                    https:\/\/doi.org\/10.1681\/asn.2004040275","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"1906_CR4","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1681\/asn.2014050472","volume":"26","author":"MB Rivara","year":"2015","unstructured":"Rivara MB, Ravel V, Kalantar-Zadeh K, Streja E, Lau WL, Nissenson AR, Kestenbaum B, de Boer IH, Himmelfarb J, Mehrotra R (2015) Uncorrected and albumin-corrected calcium, phosphorus, and mortality in patients undergoing maintenance dialysis. J Am Soc Nephrol 26(7):1671\u20131681. \n                    https:\/\/doi.org\/10.1681\/asn.2014050472","journal-title":"J Am Soc Nephrol"},{"issue":"3","key":"1906_CR5","doi-asserted-by":"publisher","first-page":"468","DOI":"10.2215\/CJN.06040809","volume":"5","author":"CP Kovesdy","year":"2010","unstructured":"Kovesdy CP, Kuchmak O, Lu JL, Kalantar-Zadeh K (2010) Outcomes associated with serum calcium level in men with non-dialysis-dependent chronic kidney disease. Clin J Am Soc Nephrol 5(3):468\u2013476. \n                    https:\/\/doi.org\/10.2215\/CJN.06040809","journal-title":"Clin J Am Soc Nephrol"},{"issue":"5","key":"1906_CR6","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S0272-6386(12)80059-X","volume":"16","author":"F Meric","year":"1990","unstructured":"Meric F, Yap P, Bia MJ (1990) Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy. Am J Kidney Dis 16(5):459\u2013464","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"1906_CR7","doi-asserted-by":"publisher","first-page":"694","DOI":"10.1016\/S0272-6386(99)70221-0","volume":"33","author":"AJ Bleyer","year":"1999","unstructured":"Bleyer AJ, Burke SK, Dillon M, Garrett B, Kant KS, Lynch D, Rahman SN, Schoenfeld P, Teitelbaum I, Zeig S, Slatopolsky E (1999) A comparison of the calcium-free phosphate binder sevelamer hydrochloride with calcium acetate in the treatment of hyperphosphatemia in hemodialysis patients. Am J Kidney Dis 33(4):694\u2013701","journal-title":"Am J Kidney Dis"},{"issue":"11","key":"1906_CR8","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","volume":"69","author":"S Moe","year":"2006","unstructured":"Moe S, Drueke T, Cunningham J, Goodman W, Martin K, Olgaard K, Ott S, Sprague S, Lameire N, Eknoyan G (2006) Definition, evaluation, and classification of renal osteodystrophy: a position statement from kidney disease: improving global outcomes (KDIGO). Kidney Int 69(11):1945\u20131953. \n                    https:\/\/doi.org\/10.1038\/sj.ki.5000414","journal-title":"Kidney Int"},{"issue":"9403","key":"1906_CR9","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/s0140-6736(03)15268-3","volume":"363","author":"WHO Expert Consultation","year":"2004","unstructured":"WHO Expert Consultation (2004) Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet 363(9403):157\u2013163. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(03)15268-3","journal-title":"Lancet"},{"key":"1906_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1748-5908-8-1","volume":"8","author":"M Pai","year":"2013","unstructured":"Pai M, Lloyd NS, Cheng J, Thabane L, Spencer FA, Cook DJ, Haynes RB, Schunemann HJ, Douketis JD (2013) Strategies to enhance venous thromboprophylaxis in hospitalized medical patients (SENTRY): a pilot cluster randomized trial. Implement Sci 8:1. \n                    https:\/\/doi.org\/10.1186\/1748-5908-8-1","journal-title":"Implement Sci"},{"issue":"5893","key":"1906_CR11","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1136\/bmj.4.5893.643","volume":"4","author":"RB Payne","year":"1973","unstructured":"Payne RB, Little AJ, Williams RB, Milner JR (1973) Interpretation of serum calcium in patients with abnormal serum proteins. BMJ 4(5893):643\u2013646","journal-title":"BMJ"},{"issue":"9","key":"1906_CR12","first-page":"1959","volume":"67","author":"MF Carroll","year":"2003","unstructured":"Carroll MF, Schade DS (2003) A practical approach to hypercalcemia. Am Fam Physician 67(9):1959\u20131966","journal-title":"Am Fam Physician"},{"key":"1906_CR13","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1186\/1471-2369-13-116","volume":"13","author":"X Kong","year":"2012","unstructured":"Kong X, Zhang L, Zhang L, Chen N, Gu Y, Yu X, Liu W, Chen J, Peng L, Yuan W, Wu H, Chen W, Fan M, He L, Ding F, Chen X, Xiong Z, Zhang J, Jia Q, Shi W, Xing C, Tang X, Hou F, Shu G, Mei C, Wang L, Xu D, Ni Z, Zuo L, Wang M, Wang H (2012) Mineral and bone disorder in Chinese dialysis patients: a multicenter study. BMC Nephrol 13:116. \n                    https:\/\/doi.org\/10.1186\/1471-2369-13-116","journal-title":"BMC Nephrol"},{"issue":"4","key":"1906_CR14","doi-asserted-by":"publisher","first-page":"460","DOI":"10.4103\/2230-8210.183457","volume":"20","author":"S Vikrant","year":"2016","unstructured":"Vikrant S, Parashar A (2016) Prevalence and severity of disordered mineral metabolism in patients with chronic kidney disease: a study from a tertiary care hospital in India. Indian J Endocrinol Metab 20(4):460\u2013467. \n                    https:\/\/doi.org\/10.4103\/2230-8210.183457","journal-title":"Indian J Endocrinol Metab"},{"issue":"4","key":"1906_CR15","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1097\/01.smj.0000210142.76331.b4","volume":"99","author":"CJ Cheng","year":"2006","unstructured":"Cheng CJ, Chou CH, Lin SH (2006) An unrecognized cause of recurrent hypercalcemia: immobilization. South Med J 99(4):371\u2013374. \n                    https:\/\/doi.org\/10.1097\/01.smj.0000210142.76331.b4","journal-title":"South Med J"},{"issue":"2","key":"1906_CR16","doi-asserted-by":"publisher","first-page":"E40","DOI":"10.1111\/hdi.12512","volume":"21","author":"HK Teo","year":"2017","unstructured":"Teo HK, Wong J (2017) Unusual cause of hypercalcaemia in end stage renal failure patients. Hemodial Int 21(2):E40\u2013E44. \n                    https:\/\/doi.org\/10.1111\/hdi.12512","journal-title":"Hemodial Int"},{"issue":"27","key":"1906_CR17","doi-asserted-by":"publisher","first-page":"16744","DOI":"10.1074\/jbc.M114.628313","volume":"290","author":"JM Spatz","year":"2015","unstructured":"Spatz JM, Wein MN, Gooi JH, Qu Y, Garr JL, Liu S, Barry KJ, Uda Y, Lai F, Dedic C, Balcells-Camps M, Kronenberg HM, Babij P, Pajevic PD (2015) The Wnt inhibitor sclerostin is up-regulated by mechanical unloading in osteocytes in vitro. J Biol Chem 290(27):16744\u201316758. \n                    https:\/\/doi.org\/10.1074\/jbc.M114.628313","journal-title":"J Biol Chem"},{"issue":"12","key":"1906_CR18","doi-asserted-by":"publisher","first-page":"840","DOI":"10.7326\/0003-4819-147-12-200712180-00004","volume":"147","author":"SC Palmer","year":"2007","unstructured":"Palmer SC, McGregor DO, Macaskill P, Craig JC, Elder GJ, Strippoli GF (2007) Meta-analysis: vitamin D compounds in chronic kidney disease. Ann Intern Med 147(12):840\u2013853","journal-title":"Ann Intern Med"},{"issue":"7","key":"1906_CR19","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1001\/jama.2012.120","volume":"307","author":"R Thadhani","year":"2012","unstructured":"Thadhani R, Appelbaum E, Pritchett Y, Chang Y, Wenger J, Tamez H, Bhan I, Agarwal R, Zoccali C, Wanner C, Lloyd-Jones D, Cannata J, Thompson BT, Andress D, Zhang W, Packham D, Singh B, Zehnder D, Shah A, Pachika A, Manning WJ, Solomon SD (2012) Vitamin D therapy and cardiac structure and function in patients with chronic kidney disease: the PRIMO randomized controlled trial. Jama 307(7):674\u2013684. \n                    https:\/\/doi.org\/10.1001\/jama.2012.120","journal-title":"Jama"},{"issue":"1","key":"1906_CR20","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1681\/asn.2013010103","volume":"25","author":"AY Wang","year":"2014","unstructured":"Wang AY, Fang F, Chan J, Wen YY, Qing S, Chan IH, Lo G, Lai KN, Lo WK, Lam CW, Yu CM (2014) Effect of paricalcitol on left ventricular mass and function in CKD\u2014the OPERA trial. J Am Soc Nephrol 25(1):175\u2013186. \n                    https:\/\/doi.org\/10.1681\/asn.2013010103","journal-title":"J Am Soc Nephrol"},{"key":"1906_CR21","doi-asserted-by":"publisher","first-page":"212302","DOI":"10.7573\/dic.212302","volume":"6","author":"RJ Wilson","year":"2017","unstructured":"Wilson RJ, Copley JB (2017) Elemental calcium intake associated with calcium acetate\/calcium carbonate in the treatment of hyperphosphatemia. Drugs Context 6:212302. \n                    https:\/\/doi.org\/10.7573\/dic.212302","journal-title":"Drugs Context"},{"issue":"12","key":"1906_CR22","doi-asserted-by":"publisher","first-page":"e0144119","DOI":"10.1371\/journal.pone.0144119","volume":"10","author":"S Ghimire","year":"2015","unstructured":"Ghimire S, Castelino RL, Lioufas NM, Peterson GM, Zaidi STR (2015) Nonadherence to medication therapy in haemodialysis patients: a systematic review. PLoS ONE 10(12):e0144119. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0144119","journal-title":"PLoS ONE"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11255-018-1906-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1906-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-018-1906-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,6]],"date-time":"2019-06-06T19:07:45Z","timestamp":1559848065000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11255-018-1906-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,7]]},"references-count":22,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["1906"],"URL":"https:\/\/doi.org\/10.1007\/s11255-018-1906-x","relation":{},"ISSN":["0301-1623","1573-2584"],"issn-type":[{"value":"0301-1623","type":"print"},{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,7]]},"assertion":[{"value":"15 February 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 May 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}